Skip to main content
Switching to fulvestrant + palbociclib benefits ER + HER2− BC patients with rising bESR1mut
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Switching to fulvestrant + palbociclib benefits ER + HER2− BC patients with rising bESR1mut
User login
Username
Password
Reset your password
Concept
Lead
score
Advanced and Metastatic Breast Cancer
1
1
Breast Cancer
0
1
Epidermal Growth Factor Receptor
0
0.85
Breast
0
0.55
Cancer
0
0.55
Estrogen
0
0.15
Specialty
Lead
score
Hematology-Oncology
1
1
Pharmacist
0
0.83
Ob/Gyn & Women's Health
0
0.81
Edit Tags